A carregar...

Biomarkers in prostate cancer: what’s new?

PURPOSE OF REVIEW: This review is intended to provide an overview of the current state of biomarkers for prostate cancer (PCa), with a focus on biomarkers approved by the US Food and Drug Administration (FDA) as well as biomarkers available from Clinical Laboratory Improvement Amendment (CLIA)-certi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sartori, David A., Chan, Daniel W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4110681/
https://ncbi.nlm.nih.gov/pubmed/24626128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000065
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!